Bionime Corporation (TPE:4737)

Bionime Revenue

Bionime had revenue of 405.26M TWD in the quarter ending March 31, 2026, a decrease of -15.82%. This brings the company's revenue in the last twelve months to 1.76B, down -9.47% year-over-year. In the year 2025, Bionime had annual revenue of 1.84B, down -4.92%.

• Revenue (ttm): 1.76B
• Revenue Growth: -9.47%
• P/S Ratio: 2.18
• Revenue / Employee: 3.52M
• Employees: 500
• Market Cap: 3.84B

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2025	1.84B	-95.16M	-4.92%
Dec 31, 2024	1.93B	178.18M	10.15%
Dec 31, 2023	1.76B	-455.02M	-20.58%
Dec 31, 2022	2.21B	360.67M	19.50%
Dec 31, 2021	1.85B	181.34M	10.87%

Data Source: S&P Global Market Intelligence Last updated: Mar 31, 2026

Revenue data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

May 30, 2026

Data Sources Report a data error